Using the MR-Base Platform to Investigate Risk Factors and Drug Targets for Thousands of Phenotypes
Wellcome Open Research - United Kingdom
doi 10.12688/wellcomeopenres.15334.1
Full Text
Open PDFAbstract
Available in full text
Date
July 29, 2019
Authors
Publisher
F1000 Research Ltd